CommentariesAre drug and placebo effects in depression additive?
Section snippets
Acknowledgements
Aspects of this work were presented at the conference “Clinical Trials in Mood Disorders: The Use of Placebo … Past, Present, and Future,” September 14–15, 1999, Washington, DC. The conference was sponsored by the National Depressive and Manic-Depressive Association through unrestricted educational grants provided by Abbott Laboratories, Bristol-Myers Squibb Company, Forest Laboratories, Inc., Glaxo Wellcome Inc., Janssen Pharmaceutica Products, L.P., Merck & Company, Pfizer Inc., Pharmacia &
References (10)
- et al.
Raising questions about antidepressants
Psychother Psychosom
(1999) Can placebo be the cure?
Science
(1999)- et al.
How sound is the double-blind design for evaluating psychotropic drugs
J Nerv Ment Dis
(1993) - et al.
Antidepressant treatment of depressionA metaanalysis
Can J Psychiatry
(1996) Changing ExpectationsA Key to Effective Psychotherapy
(1990)
Cited by (114)
When distress becomes disease: The social context and uses of disease attributions in common mental disorder
2022, SSM - Qualitative Research in HealthCausal models accounted for research participation effects when estimating effects in a behavioral intervention trial
2021, Journal of Clinical EpidemiologyCitation Excerpt :The reasoning goes that all participants are involved in such activities in RCTs, and those differences among participants will be equally divided between treatment groups due to randomization. Also, the assumption is generally that any influence that prerandomization activities may have on the intended outcome will be additive, and thus separate from the effects of the intervention under study, leaving group level measurements at follow-up equivalently shifted and contrasts unchanged [5,11]. Evidence of this conventional view can be found in almost all reports of RCTs, where analyses typically consist of regression models which aid the contrast of two or more groups of individuals receiving different treatments.
Strategies to minimize placebo effects in research investigations
2020, International Review of NeurobiologyThe placebo and its effects: A psychoneuroendocrinological perspective
2019, PsychoneuroendocrinologyCitation Excerpt :Thus, placebos and their effects qualify as true instances of a psychobiological treatment. Its potential is further amplified when considering that placebos are an integral and immanent component of virtually all interventions as its effects add to or even interact with the proposedly active treatment components (Kirsch, 2000; Lund et al., 2014). Placebos are – similar to basically any treatment – administered within the communicative process of the clinical encounter, resulting in the generation of a therapeutic meaning and a subsequent meaning response (Moerman and Jonas, 2002).